Bruker falls after prelim Q2 revenue forecast comes below estimate

Shares of medical equipment maker Bruker Corp BRKR.O down 9.3% at $36.79

Company expects Q2 preliminary revenue to be between $795 million and $798 million, compared with analysts' estimate of $810.8 million - data compiled by LSEG

Expects Q2 per-share profit in the range of $0.32 to $0.34, compared with the estimate of $0.42

"We think it's important to keep in mind that BRKR is levered to discovery stages of academic and biopharma end-markets — a segment that has been weak on NIH cuts and minimal biotech funding," Leerink Partners analysts say in a note

Including session's move, BRKR shares down 37.4% YTD